PACTR202404544467702尚未招募3 期
Seasonal R21 mass vaccination for malaria elimination (SERVAL)
ondon School of Hygiene and Tropical Medicine0 个研究点目标入组 16,200 人开始时间: 2023年9月26日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 16,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 Month(s) 至 23 Month(s)（—）
- 性别
- All
入选标准
- •1.Age= 5 months.
- •2.Willingness to comply with trial procedures.
- •3.Individual written informed consent obtained at the beginning of the study.
排除标准
- •1.Pregnancy
- •2.History of allergic disease or reactions likely to be exacerbated by any component of the vaccines, e.g., Kathon, neomycin, betapropiolactone.
- •3.Any history of anaphylaxis in relation to vaccination.
- •4.Known chronic illness.
- •5.Any other significant disease, disorder or situation which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant’s ability to participate in the trial.
研究者
相似试验
招募中
3 期
Seasonal R21 Mass Vaccination for Malaria EliminationMalariaNCT06578572London School of Hygiene and Tropical Medicine16,200
进行中（未招募）
3 期
The acceptability of seasonal antimalarial medication in Korogho, Côte d'IvoireInfections and InfestationsUnspecified malariaMalariaISRCTN17164969Institut de Recherche en Sciences de la Santé1,701
已完成
1 期
Adenovirus Vaccine for MalariaPlasmodium Falciparum InfectionNCT00371189National Institute of Allergy and Infectious Diseases (NIAID)75
尚未招募
3 期
Broad One Health Endectocide-based Malaria Intervention in Africa - BOHEMIA: A Phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings.MalariaPACTR202106695877303Barcelona Institute for GlobalHealth53,000
已完成
1 期
EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum MalariaPlasmodium Falciparum MalariaNCT01169077National Institute of Allergy and Infectious Diseases (NIAID)39